|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net earnings | |||||
| Items not involving cash: | |||||
| Depreciation and amortization | |||||
| Goodwill impairment (note 11) | |||||
| Change in right-of-use asset | |||||
| Non-cash interest expense and accretion | |||||
| Non-cash adjustment purchase option finance lease | |||||
| Unrealized change in derivative instruments | |||||
| Amortization of acquired revenue contracts | |||||
| Loss on debt extinguishment | |||||
| Income from equity investment | |||||
| (Gain) loss on sale | |||||
| Other | |||||
| Change in other operating assets and liabilities (note 20) | |||||
| Cash from operating activities | |||||
| Cash from operating activities from continuing operations | |||||
| Cash from operating activities from discontinued operations (note 23) | |||||
| Investing activities: | |||||
| Expenditures for property, plant and equipment and vessels under construction | |||||
| Prepayment on vessel purchase | |||||
| Cash and restricted cash acquired from APR Energy acquisition | |||||
| Receipt (Payment) on settlement of interest swap agreements | |||||
| Gain on foreign currency repatriation | |||||
| Receipt from contingent consideration asset | |||||
| Other assets and liabilities | |||||
| Capitalized interest relating to newbuilds | |||||
| Cash used in investing activities | |||||
| Cash used in investing activities from continuing operations | |||||
| Cash from (used in) investing activities from discontinued operations (note 23) | |||||
| Financing activities: | |||||
| Repayments of long-term debt and other financing arrangements | |||||
| Issuance of long-term debt and other financing arrangements | |||||
| Issuance of Exchangeable Notes | |||||
| Purchase of capped call | |||||
| Capital contribution from Poseidon | |||||
| Redemption of Fairfax Notes | |||||
| Issuance of Fairfax Notes | |||||
| Capped call settlement | |||||
| Proceeds from exercise of warrants | |||||
| Redemption of preferred shares | |||||
| Payment of lease liabilities | |||||
| Financing fees | |||||
| Share issuance cost | |||||
| Dividends on common shares | |||||
| Dividends on preferred shares | |||||
| Cash from financing activities | |||||
| Cash and cash equivalents and restricted cash, beginning of year | |||||
| Cash from financing activities from continuing operations | |||||
| Cash used in financing activities from discontinued operations (note 23) | |||||
| Increase in cash and cash equivalents from continuing operations | |||||
| Increase (Decrease) in cash and cash equivalents from discontinued operations | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash, end of year from continuing and discontinued operations | |||||
Loading...